• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. LIPASE REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. LIPASE REAGENT Back to Search Results
Model Number LIPASE REAGENT
Device Problems Nonstandard Device (1420); Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/25/2015
Event Type  malfunction  
Event Description
The customer has obtained lower results on twenty samples for lipase.The sample values obtained on the first run were higher than when the samples were repeated on the same advia chemistry 2400 instrument.Eighteen of the twenty samples were rerun on an advia chemistry 1650 and the results were different.It is unknown if any of the results obtained on the advia chemistry 2400 or 1650 were reported to physician(s).There were no reports of adverse health consequences due to the results obtained for lipase on the patient samples.
 
Manufacturer Narrative
Siemens healthcare diagnostics has identified the potential for high biased advia® chemistry systems lipase assay results due to carryover from one or more of the following tests: triglycerides, triglycerides _2, triglycerides concentrated, cholesterol concentrated, and direct ldl reagents.The root cause of this issue was determined to be inadequate contamination avoidance settings between lipase and lipid panel assays (triglycerides, chol_c and dldl).An urgent medical device correction (umdc) 11220133, rev.A was sent to us customers and an urgent field safety notice (ufsn) 11220075, rev.A was sent to ous customers in march of 2015.The umdc and ufsn state that customers are advised to continue using the advia chemistry lipase reagents and follow the rerun instructions in the customer letter if a high outlier is observed.The customer has received and implemented the protocol provided in the ufsn, and the issue has been resolved.The instrument is performing according to specifications.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIPASE REAGENT
Type of Device
LIPASE REAGENT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
RANDOX LABORATORIES LTD
55 diamon road
crumlin
co. antrim, BT29 4QY
UK   BT29 4QY
Manufacturer Contact
aarti aziz
511 benedict avenue
tarrytown, NY 10591
9145242683
MDR Report Key4712425
MDR Text Key5662044
Report Number2432235-2015-00193
Device Sequence Number1
Product Code CHI
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Health Professional
Remedial Action Recall
Type of Report Initial
Report Date 03/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberLIPASE REAGENT
Device Catalogue NumberB01-4840-01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/26/2015
Initial Date FDA Received04/21/2015
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number2432235-03/24/2015-002-C
Patient Sequence Number1
-
-